28.07.2009 10:00:00
|
Centene Corporation Reports 2009 Second Quarter Earnings
Centene Corporation (NYSE: CNC) today announced its net earnings from continuing operations for the quarter ended June 30, 2009 were $20.7 million, or $0.47 per diluted share, compared to $17.9 million, or $0.40 per diluted share in the 2008 second quarter. The results of operations for our New Jersey health plan, University Health Plans, are classified as discontinued operations. The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios are calculated using revenues excluding premium taxes and investment income.
Second Quarter Highlights
- Quarter-end managed care at-risk membership of 1,289,000, an increase of 140,200 lives year over year.
- Premium and Service revenues of $931.3 million, representing 16.1% year over year growth.
- Health Benefits Ratio (HBR) of 83.1%.
- General and administrative (G&A) expense ratio of 13.9%.
- Cash flow from operations of $38.7 million, which is 2.0x net earnings.
- Days in claims payable of 47.5, an increase from 45.3 days at March 31, 2009.
- Diluted earnings per share from continuing operations of $0.47, representing 17.5% year over year growth.
- Increased 2009 EPS guidance range to $1.88-$1.96.
Other Events
- On July 1, 2009, CeltiCare Health Plan of Massachusetts began serving the Central, Northern, Boston and Southern regions under the Commonwealth Care program. CeltiCare was also recently granted a seal of approval by the Commonwealth Connector Authority for the Commonwealth Choice program. Commonwealth Choice is part of Massachusetts’ health care program, serving the individual and small group market and is not a subsidized program. CeltiCare now participates in two of the three health coverage programs in Massachusetts.
- In July 2009, the Company was awarded a tentative contract from the Texas Health and Human Services Commission (HHSC) for the Children’s Health Insurance Program (CHIP) Rural Services Area Managed Care Organization Procurement. The award is contingent upon the successful negotiation and execution of a contract with HHSC. Our Texas health plan will begin serving members under the new contract on September 1, 2010, continuing through August 31, 2013. The award covers up to 174 primarily rural counties in Texas.
Michael F. Neidorff, Centene’s Chairman and Chief Executive Officer, stated, "We are pleased that our strategic and operational focus on fundamentals continues to drive this positive operating momentum.”
The following table depicts membership in Centene’s managed care organizations, by state, at June 30, 2009 and 2008:
June 30, | |||||
2009 | 2008 | ||||
Arizona | 16,200 |
-- |
|||
Florida | 22,300 |
-- |
|||
Georgia | 292,800 | 278,800 | |||
Indiana | 196,100 | 161,700 | |||
Ohio | 141,200 | 137,300 | |||
South Carolina | 46,000 | 22,500 | |||
Texas | 443,200 | 423,700 | |||
Wisconsin | 131,200 | 124,800 | |||
Total at-risk membership | 1,289,000 | 1,148,800 | |||
Non-risk membership |
114,000 |
* |
3,500 | ||
Total | 1,403,000 | 1,152,300 | |||
______________________________ | |||||
* Increase mainly due to consolidation of our Access Health Solutions LLC investment, effective January 1, 2009. | |||||
The following table depicts membership in Centene’s managed care organizations, by member category, at June 30, 2009 and 2008:
June 30, | ||||
2009 | 2008 | |||
Medicaid | 958,600 | 828,700 | ||
CHIP & Foster Care | 261,400 | 256,900 | ||
ABD & Medicare | 69,000 | 63,200 | ||
Total at-risk membership | 1,289,000 | 1,148,800 | ||
Non-risk membership | 114,000 | 3,500 | ||
Total | 1,403,000 | 1,152,300 | ||
Statement of Operations
- For the 2009 second quarter, Premium and Service Revenues increased 16.1% to $931.3 million from $802.5 million in the 2008 second quarter. The increase was primarily driven by membership growth, especially related to the commencement of our Arizona acute care contract in October 2008, the consolidation of Access and conversion of members to our at-risk plan, premium rate increases and the recent acquisition of Celtic in July 2008.
- The consolidated HBR, which reflects medical costs as a percent of premium revenues, was 83.1%, relatively flat compared to 83.0% in the 2008 second quarter. Sequentially, our consolidated HBR decreased from 83.5% in the 2009 first quarter to 83.1% as a result of normal seasonality. During the second quarter, an increase in outpatient expense attributable to swine flu concerns was offset by lower inpatient and pharmacy costs.
- Consolidated G&A expense as a percent of premium and service revenues was 13.9% in the second quarter of 2009, an increase from 13.6% in the second quarter of 2008. G&A expense increased in the quarter ended June 30, 2009 compared to 2008 as a result of new business initiatives including the acquisition of Celtic, the consolidation of Access Health Solutions LLC and the start up of CeltiCare health plan in Massachusetts.
- Earnings per diluted share from continuing operations were $0.47, compared to $0.40 in the 2008 second quarter.
Balance Sheet and Cash Flow
At June 30, 2009, the Company had cash and investments of $852.8 million, including $825.8 million held by its regulated entities and $27.0 million held by its unregulated entities. Medical claims liabilities totaled $394.8 million, representing 47.5 days in claims payable, an increase of 2.2 days from March 31, 2009. Total debt was $288.8 million and debt to capitalization was 33.0%. Year to date cash flow from operations was $62.1 million.
A reconciliation of the Company’s change in days in claims payable from the immediately preceding quarter-end is presented below:
Days in claims payable, March 31, 2009 | 45.3 | ||
Timing of claims payments | 1.5 | ||
Increase in claims processing inventory | 1.1 | ||
Payment of annual provider bonuses | (0.4 | ) | |
Days in claims payable, June 30, 2009 | 47.5 | ||
Outlook
The table below depicts the Company’s annual guidance for 2009:
Full Year 2009 | ||||||
Low | High | |||||
Premium and Service revenues (in millions) | $ | 3,750 | $ | 3,850 | ||
Earnings per diluted share | $ | 1.88 | $ | 1.96 | ||
Conference Call
As previously announced, the Company will host a conference call Tuesday, July 28, 2009, at 8:30 A.M. (Eastern Time) to review the financial results for the second quarter ended June 30, 2009, and to discuss its business outlook. Michael F. Neidorff and William N. Scheffel will host the conference call. Investors and other interested parties are invited to listen to the conference call by dialing 800-273-1254 in the U.S. and Canada, 973-638-3440 from abroad, or via a live Internet broadcast on the Company’s website at www.centene.com, under the Investor Relations section. A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM (Eastern Time) on Tuesday, August 11, 2009, at the aforementioned URL, or by dialing 800-642-1687 in the U.S. and Canada, or 706-645-9291 from abroad, and entering access code 15407585.
About Centene Corporation
Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including the Children’s Health Insurance Program (CHIP), as well as Aged, Blind, or Disabled (ABD), Foster Care, Long-Term Care and Medicare (Special Needs Plans). The Company operates local health plans and offers a wide range of health insurance solutions to individuals and the rising number of uninsured Americans. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, pharmacy benefits management and medication adherence. Information regarding Centene is available via the Internet at www.centene.com.
The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company’s estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene’s ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene’s Medicaid Managed Care contracts by state governments would also negatively affect Centene.
[Tables Follow]
CENTENE CORPORATION AND SUBSIDIARIES |
||||||||
|
||||||||
CONSOLIDATED BALANCE SHEETS |
||||||||
(In thousands, except share data) |
||||||||
June 30, 2009 |
December 31, 2008 |
|||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents of continuing operations | $ | 382,700 | $ | 370,999 | ||||
Cash and cash equivalents of discontinued operations | 1,799 | 8,100 | ||||||
Total cash and cash equivalents | 384,499 | 379,099 | ||||||
Premium and related receivables, net of allowance for uncollectible accounts of $48 and $595, respectively | 157,863 | 92,531 | ||||||
Short-term investments, at fair value (amortized cost $60,749 and $108,469, respectively) | 61,217 | 109,393 | ||||||
Other current assets | 73,686 | 75,333 | ||||||
Current assets of discontinued operations other than cash | 8,499 | 9,987 | ||||||
Total current assets | 685,764 | 666,343 | ||||||
Long-term investments, at fair value (amortized cost $387,166 and $329,330, respectively) | 394,395 | 332,411 | ||||||
Restricted deposits, at fair value (amortized cost $14,436 and $9,124, respectively) | 14,526 | 9,254 | ||||||
Property, software and equipment, net of accumulated depreciation of $88,469 and $74,194, respectively | 194,277 | 175,858 | ||||||
Goodwill | 218,121 | 163,380 | ||||||
Intangible assets, net | 22,714 | 17,575 | ||||||
Other long-term assets | 28,957 | 59,083 | ||||||
Long-term assets of discontinued operations | 27,455 | 27,248 | ||||||
Total assets | $ | 1,586,209 | $ | 1,451,152 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Medical claims liability | $ | 394,787 | $ | 373,037 | ||||
Accounts payable and accrued expenses | 181,605 | 219,566 | ||||||
Unearned revenue | 62,958 | 17,107 | ||||||
Current portion of long-term debt | 243 | 255 | ||||||
Current liabilities of discontinued operations | 23,851 | 31,013 | ||||||
Total current liabilities | 663,444 | 640,978 | ||||||
Long-term debt | 288,513 | 264,637 | ||||||
Other long-term liabilities | 48,678 | 43,539 | ||||||
Long-term liabilities of discontinued operations | 557 | 726 | ||||||
Total liabilities | 1,001,192 | 949,880 | ||||||
Commitments and contingencies | ||||||||
Stockholders’ equity: | ||||||||
Common stock, $.001 par value; authorized 100,000,000 shares; issued and outstanding 45,344,717 and 45,071,179 shares, respectively | 45 | 45 | ||||||
Additional paid-in capital | 273,029 | 263,835 | ||||||
Accumulated other comprehensive income: | ||||||||
Unrealized gain on investments, net of tax | 5,081 | 3,152 | ||||||
Retained earnings | 313,924 | 275,236 | ||||||
Treasury stock at cost (2,369,133 and 2,083,415 shares, respectively) | (46,405 | ) | (40,996 | ) | ||||
Total Centene stockholders’ equity | 545,674 | 501,272 | ||||||
Noncontrolling interest | 39,343 |
-- |
||||||
Total stockholders’ equity | 585,017 | 501,272 | ||||||
Total liabilities and stockholders’ equity | $ | 1,586,209 |
$ |
1,451,152 |
CENTENE CORPORATION AND SUBSIDIARIES |
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(In thousands, except share data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
Revenues: | ||||||||||||||||
Premium | $ | 909,698 | $ | 783,996 | $ | 1,794,704 | $ | 1,520,810 | ||||||||
Service | 21,591 | 18,466 | 45,440 | 38,996 | ||||||||||||
Premium and service revenues | 931,289 | 802,462 | 1,840,144 | 1,559,806 | ||||||||||||
Premium tax | 108,180 | 21,468 | 131,760 | 43,352 | ||||||||||||
Total revenues | 1,039,469 | 823,930 | 1,971,904 | 1,603,158 | ||||||||||||
Expenses: | ||||||||||||||||
Medical costs | 755,706 | 650,878 | 1,495,046 | 1,260,252 | ||||||||||||
Cost of services | 14,559 | 14,437 | 30,521 | 30,613 | ||||||||||||
General and administrative expenses | 129,221 | 109,270 | 251,500 | 204,763 | ||||||||||||
Premium tax | 108,548 | 21,468 | 132,490 | 43,352 | ||||||||||||
Total operating expenses | 1,008,034 | 796,053 | 1,909,557 | 1,538,980 | ||||||||||||
Earnings from operations | 31,435 | 27,877 | 62,347 | 64,178 | ||||||||||||
Other income (expense): | ||||||||||||||||
Investment and other income | 4,418 | 5,434 | 8,031 | 13,016 | ||||||||||||
Interest expense | (4,160 | ) | (4,065 | ) | (8,146 | ) | (8,059 | ) | ||||||||
Earnings from continuing operations, before income tax expense | 31,693 | 29,246 | 62,232 | 69,135 | ||||||||||||
Income tax expense | 11,789 | 11,363 | 22,634 | 26,319 | ||||||||||||
Earnings from continuing operations, net of income tax expense | 19,904 | 17,883 | 39,598 | 42,816 | ||||||||||||
Discontinued operations, net of income tax (benefit) expense of $(196), $(116), $(356) and $148, respectively |
(485 | ) | 320 | (934 | ) | 1,010 | ||||||||||
Net earnings | 19,419 | 18,203 | 38,664 | 43,826 | ||||||||||||
Noncontrolling interest (loss) | (811 | ) | ? | (24 | ) | ? | ||||||||||
Net earnings attributable to Centene Corporation | $ | 20,230 | $ | 18,203 | $ | 38,688 | $ | 43,826 | ||||||||
Amounts attributable to Centene Corporation common shareholders: | ||||||||||||||||
Earnings from continuing operations, net of income tax expense | $ | 20,715 | $ | 17,883 | $ | 39,622 | $ | 42,816 | ||||||||
Discontinued operations, net of income tax (benefit) expense | (485 | ) | 320 | (934 | ) | 1,010 | ||||||||||
Net earnings | $ | 20,230 | $ | 18,203 | $ | 38,688 | $ | 43,826 | ||||||||
Net earnings (loss) per share attributable to Centene Corporation: | ||||||||||||||||
Basic: | ||||||||||||||||
Continuing operations | $ | 0.48 | $ | 0.41 | $ | 0.92 | $ | 0.99 | ||||||||
Discontinued operations | (0.01 | ) | 0.01 | (0.02 | ) | 0.02 | ||||||||||
Earnings per common share | $ | 0.47 | $ | 0.42 | $ | 0.90 | $ | 1.01 | ||||||||
Diluted: | ||||||||||||||||
Continuing operations | $ | 0.47 | $ | 0.40 | $ | 0.90 | $ | 0.96 | ||||||||
Discontinued operations | (0.01 | ) | 0.01 | (0.02 | ) | 0.02 | ||||||||||
Earnings per common share | $ | 0.46 | $ | 0.41 | $ | 0.88 | $ | 0.98 | ||||||||
Weighted average number of shares outstanding: | ||||||||||||||||
Basic | 43,001,157 | 43,375,944 | 43,034,390 | 43,457,076 | ||||||||||||
Diluted | 44,242,339 | 44,275,601 | 44,240,071 | 44,516,890 |
CENTENE CORPORATION AND SUBSIDIARIES |
||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
(In thousands) |
||||||||
Six Months Ended June 30, | ||||||||
2009 | 2008 | |||||||
(Unaudited) | ||||||||
Cash flows from operating activities: | ||||||||
Net earnings | $ | 38,664 | $ | 43,826 | ||||
Adjustments to reconcile net earnings to net cash provided by operating activities | ||||||||
Depreciation and amortization | 20,892 | 16,229 | ||||||
Stock compensation expense | 7,611 | 7,839 | ||||||
Loss (gain) on sale of investments, net | 450 | (201 | ) | |||||
Deferred income taxes | 1,512 | 11,879 | ||||||
Changes in assets and liabilities — |
||||||||
Premium and related receivables | (23,327 | ) | (23,144 | ) | ||||
Other current assets | 1,357 | (4,294 | ) | |||||
Other assets | (608 | ) | (1,671 | ) | ||||
Medical claims liabilities | 16,369 | 27,316 | ||||||
Unearned revenue | 44,129 | (38,753 | ) | |||||
Accounts payable and accrued expenses | (48,653 | ) | 45,907 | |||||
Other operating activities | 3,723 | 1,743 | ||||||
Net cash provided by operating activities | 62,119 | 86,676 | ||||||
Cash flows from investing activities: | ||||||||
Capital expenditures | (29,833 | ) | (34,581 | ) | ||||
Purchases of investments | (415,052 | ) | (172,873 | ) | ||||
Sales and maturities of investments | 377,320 | 210,277 | ||||||
Investments in acquisitions, net of cash acquired, and investment in equity method investee | (7,621 | ) | (7,818 | ) | ||||
Net cash used in investing activities | (75,186 | ) | (4,995 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 1,109 | 3,029 | ||||||
Proceeds from borrowings | 288,000 | 56,005 | ||||||
Payment of long-term debt | (264,135 | ) | (41,287 | ) | ||||
Dividend to noncontrolling interest | (1,749 | ) |
-- |
|||||
Contribution from noncontrolling interest | 1,042 |
-- |
||||||
Excess tax benefits from stock compensation | 15 | 2,792 | ||||||
Common stock repurchases | (5,447 | ) | (13,316 | ) | ||||
Debt issue costs | (368 | ) |
-- |
|||||
Net cash provided by financing activities | 18,467 | 7,223 | ||||||
Net increase in cash and cash equivalents | 5,400 | 88,904 | ||||||
Cash and cash equivalents, beginning of period | 379,099 | 268,584 | ||||||
Cash and cash equivalents, end of period | $ | 384,499 | $ | 357,488 | ||||
Supplemental disclosures of cash flow information: | ||||||||
Interest paid | $ | 7,658 | $ | 7,590 | ||||
Income taxes paid | $ | 31,512 | $ | 15,966 | ||||
Supplemental disclosure of non-cash investing and financing activities: | ||||||||
Contribution from noncontrolling interest | $ | 5,107 | $ |
-- |
CENTENE CORPORATION |
||||||||||||||||||||
CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA |
||||||||||||||||||||
Q2 | Q1 | Q4 | Q3 | Q2 | ||||||||||||||||
2009 | 2009 | 2008 | 2008 | 2008 | ||||||||||||||||
MEMBERSHIP | ||||||||||||||||||||
Managed Care: | ||||||||||||||||||||
Arizona | 16,200 | 15,500 | 14,900 |
-- |
-- |
|||||||||||||||
Florida | 22,300 | 29,100 |
-- |
-- |
-- |
|||||||||||||||
Georgia | 292,800 | 289,300 | 288,300 | 283,900 | 278,800 | |||||||||||||||
Indiana | 196,100 | 179,100 | 175,300 | 172,400 | 161,700 | |||||||||||||||
Ohio | 141,200 | 137,000 | 133,400 | 132,500 | 137,300 | |||||||||||||||
South Carolina | 46,000 | 48,500 | 31,300 | 26,600 | 22,500 | |||||||||||||||
Texas | 443,200 | 421,100 | 428,000 | 433,200 | 423,700 | |||||||||||||||
Wisconsin | 131,200 | 127,700 | 124,800 | 122,500 | 124,800 | |||||||||||||||
Total at-risk membership | 1,289,000 | 1,247,300 | 1,196,000 | 1,171,100 | 1,148,800 | |||||||||||||||
Non-risk membership | 114,000 | 96,000 | 3,700 | 3,700 | 3,500 | |||||||||||||||
TOTAL | 1,403,000 | 1,343,300 | 1,199,700 | 1,174,800 | 1,152,300 | |||||||||||||||
Medicaid | 958,600 | 921,100 | 877,400 | 850,500 | 828,700 | |||||||||||||||
CHIP & Foster Care |
261,400 | 256,900 | 257,300 | 261,800 | 256,900 | |||||||||||||||
ABD & Medicare | 69,000 | 69,300 | 61,300 | 58,800 | 63,200 | |||||||||||||||
Total at-risk membership | 1,289,000 | 1,247,300 | 1,196,000 | 1,171,100 | 1,148,800 | |||||||||||||||
Non-risk membership | 114,000 | 96,000 | 3,700 | 3,700 | 3,500 | |||||||||||||||
TOTAL | 1,403,000 | 1,343,300 | 1,199,700 | 1,174,800 | 1,152,300 | |||||||||||||||
Specialty Services(a): |
||||||||||||||||||||
Cenpatico Behavioral Health | ||||||||||||||||||||
Arizona | 110,500 | 104,700 | 105,000 | 102,400 | 99,400 | |||||||||||||||
Kansas | 41,100 | 40,600 | 41,100 | 40,100 | 40,000 | |||||||||||||||
Bridgeway Health Solutions | ||||||||||||||||||||
Long-term Care | 2,400 | 2,300 | 2,100 | 1,900 | 1,800 | |||||||||||||||
TOTAL | 154,000 | 147,600 | 148,200 | 144,400 | 141,200 | |||||||||||||||
(a) Includes external membership only. |
||||||||||||||||||||
REVENUE PER MEMBER(b) |
$ | 219.75 | $ | 220.29 | $ | 218.52 | $ | 213.28 | $ | 214.76 | ||||||||||
CLAIMS(b) | ||||||||||||||||||||
Period-end inventory |
362,200 |
|
325,000 |
|
269,300 |
|
323,200 |
|
389,100 |
|
||||||||||
Average inventory | 234,500 | 267,600 | 288,600 | 298,400 | 235,300 | |||||||||||||||
Period-end inventory per member | 0.28 | 0.26 | 0.23 | 0.28 | 0.34 | |||||||||||||||
(b) Revenue per member and claims information are presented for the Managed Care at-risk members. |
Q2 | Q1 | Q4 | Q3 | Q2 | ||||||||||||||||
2009 | 2009 | 2008 | 2008 | 2008 | ||||||||||||||||
DAYS IN CLAIMS PAYABLE (c) |
47.5 | 45.3 | 48.5 | 47.9 | 47.8 | |||||||||||||||
(c) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period. | ||||||||||||||||||||
CASH AND INVESTMENTS (in millions) | ||||||||||||||||||||
Regulated | $ | 825.8 | $ | 816.8 | $ | 798.0 | $ | 692.6 | $ | 653.1 | ||||||||||
Unregulated | 27.0 | 28.9 | 24.1 | 26.8 | 29.0 | |||||||||||||||
TOTAL | $ | 852.8 | $ | 845.7 | $ | 822.1 | $ | 719.4 | $ | 682.1 | ||||||||||
DEBT TO CAPITALIZATION (d) |
33.0 | % | 34.6 | % | 34.6 | % | 34.4 | % | 32.6 | % | ||||||||||
(d) Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity). |
OPERATING RATIOS: |
|||||||||||||||
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||
2009 | 2008 | 2009 | 2008 | ||||||||||||
Health Benefits Ratios | |||||||||||||||
Medicaid and CHIP |
83.7 | % | 81.6 | % | 84.2 | % | 80.4 | % | |||||||
ABD and Medicare | 82.6 | 88.5 | 82.0 | 93.0 | |||||||||||
Specialty Services | 79.8 | 86.2 | 79.0 | 85.2 | |||||||||||
Total | 83.1 | 83.0 | 83.3 | 82.9 | |||||||||||
Total General & Administrative Expense Ratio | 13.9 | % | 13.6 | % | 13.7 | % | 13.1 | % |
MEDICAL CLAIMS LIABILITIES (In thousands) |
|||
Four rolling quarters of the changes in medical claims liabilities are summarized as follows: |
|||
Balance, June 30, 2008 | $ | 340,456 | |
Acquisitions | 15,398 | ||
Incurred related to: | |||
Current period | 2,924,510 | ||
Prior period | (49,381 | ) | |
Total incurred | 2,875,129 | ||
Paid related to: | |||
Current period | 2,558,425 | ||
Prior period | 277,771 | ||
Total paid | 2,836,196 | ||
Balance, June 30, 2009 | $ | 394,787 | |
Centene’s claims reserving process utilizes a consistent actuarial methodology to estimate Centene’s ultimate liability. Any reduction in the "Incurred related to: Prior period” claims may be offset as Centene actuarially determines "Incurred related to: Current period.” As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.
The amount of the "Incurred related to: Prior period” above includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, increased receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to June 30, 2008.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Centene Corp.mehr Nachrichten
28.11.24 |
S&P 500-Wert Centene-Aktie: So viel Verlust hätte eine Centene-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
21.11.24 |
S&P 500-Papier Centene-Aktie: So viel Verlust hätte ein Centene-Investment von vor einem Jahr eingebracht (finanzen.at) | |
14.11.24 |
S&P 500-Wert Centene-Aktie: So viel hätten Anleger mit einem Investment in Centene von vor 10 Jahren verdient (finanzen.at) | |
07.11.24 |
S&P 500-Wert Centene-Aktie: So viel hätten Anleger an einem Centene-Investment von vor 5 Jahren verdient (finanzen.at) | |
31.10.24 |
S&P 500-Papier Centene-Aktie: So viel Verlust hätte ein Centene-Investment von vor 3 Jahren eingefahren (finanzen.at) | |
28.10.24 |
Gute Stimmung in New York: S&P 500 beendet den Montagshandel im Plus (finanzen.at) | |
28.10.24 |
Starker Wochentag in New York: S&P 500-Börsianer greifen am Montagnachmittag zu (finanzen.at) | |
28.10.24 |
Handel in New York: Das macht der S&P 500 am Montagmittag (finanzen.at) |
Analysen zu Centene Corp.mehr Analysen
Aktien in diesem Artikel
Centene Corp. | 56,60 | -0,23% |
Indizes in diesem Artikel
S&P 600 SmallCap | 935,46 | -0,94% |